Clinical Trial Update: Topical Timolol for the Treatment of Benign Vascular Periocular Lesions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating topical timolol for benign vascular periocular lesions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Vascular Periocular Lesions

Drugs mentioned

• Timolol (topical) (timolol)

Snippet

Sponsor: Loyola University | Conditions: Benign Vascular Periocular Lesions | Phase 4 | Status: WITHDRAWN